Member of the Association of American Physicians
The scientist’s investigation covers issues in Radiation therapy, Immunotherapy, Immunology, Immune system and Cancer research. Her studies deal with areas such as Cancer and Abscopal effect as well as Radiation therapy. She combines subjects such as Radiation oncology, Oncology and Antigen with her study of Abscopal effect.
The study incorporates disciplines such as T cell, CD8 and Transplantation in addition to Immunotherapy. Her Tumor microenvironment, Inflammation and Immunosurveillance study in the realm of Immunology connects with subjects such as Barnesiella intestinihominis. Her research in Immune system intersects with topics in Cancer cell and Ovarian cancer.
Silvia C. Formenti mainly focuses on Radiation therapy, Breast cancer, Internal medicine, Cancer research and Oncology. Her biological study spans a wide range of topics, including Cancer, Abscopal effect, Immunotherapy and Clinical trial. Her Immunotherapy research integrates issues from T cell and Blockade.
As a member of one scientific family, Silvia C. Formenti mostly works in the field of Breast cancer, focusing on Prone position and, on occasion, Supine position. Silvia C. Formenti performs integrative study on Cancer research and Ionizing radiation. Her Oncology study typically links adjacent topics like Combined Modality Therapy.
Silvia C. Formenti mainly investigates Radiation therapy, Internal medicine, Cancer research, Immunotherapy and Immune system. Her Radiation therapy research is multidisciplinary, relying on both Cancer, Medical physics, Immunology and Clinical trial. Her Internal medicine research incorporates themes from Gastroenterology and Oncology.
Her Cancer research research includes themes of Cancer cell, T cell, Interferon, CD8 and Breast cancer. The various areas that Silvia C. Formenti examines in her Immunotherapy study include Tumor microenvironment, Radiosurgery and Blockade. Her Immune system research includes elements of Adjuvant, Receptor, Cytokine and Effector.
Radiation therapy, Cancer research, Immune system, Immune checkpoint and Abscopal effect are her primary areas of study. Her Radiation therapy research incorporates elements of Tumor microenvironment, Cancer, Immunotherapy and Immunology. Silvia C. Formenti has included themes like Cancer cell and Interferon in her Cancer research study.
Her study in Immune system is interdisciplinary in nature, drawing from both Context, Breast cancer, Stereotactic radiation therapy and Abemaciclib. Silvia C. Formenti focuses mostly in the field of Abscopal effect, narrowing it down to matters related to Blockade and, in some cases, Cytotoxic T cell, CTLA-4 and T cell. Her work in Internal medicine addresses subjects such as Oncology, which are connected to disciplines such as Combined Modality Therapy and Stage.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vétizou;Marie Vétizou;Marie Vétizou;Jonathan M. Pitt;Jonathan M. Pitt;Jonathan M. Pitt;Romain Daillère;Romain Daillère;Romain Daillère;Patricia Lepage.
Fractionated but not single dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody
M. Zahidunnabi Dewan;Ashley E. Galloway;Noriko Kawashima;J. Keith Dewyngaert.
Clinical Cancer Research (2009)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Sandra Demaria;Bruce Ng;Mary Louise Devitt;James S Babb.
International Journal of Radiation Oncology Biology Physics (2004)
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
Abram Recht;Stephen B. Edge;Lawrence J. Solin;David S. Robinson.
Journal of Clinical Oncology (2001)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.
Claire Vanpouille-Box;Amandine Alard;Amandine Alard;Molykutty J. Aryankalayil;Yasmeen Sarfraz.
Nature Communications (2017)
Translational control in cancer.
Deborah Silvera;Silvia C. Formenti;Robert J. Schneider.
Nature Reviews Cancer (2010)
Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.
Sandra Demaria;Noriko Kawashima;Anne Marie Yang;Mary Louise Devitt.
Clinical Cancer Research (2005)
Systemic effects of local radiotherapy
Silvia C Formenti;Sandra Demaria.
Lancet Oncology (2009)
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Silvia C. Formenti;Sandra Demaria.
Journal of the National Cancer Institute (2013)
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
Narek Shaverdian;Aaron E Lisberg;Krikor Bornazyan;Darlene Veruttipong.
Lancet Oncology (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: